Gilder Gagnon Howe & Co. LLC Reduces Position in Inspire Medical Systems, Inc. (NYSE:INSP)

Gilder Gagnon Howe & Co. LLC lowered its stake in Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) by 15.9% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 187,693 shares of the company's stock after selling 35,433 shares during the period. Gilder Gagnon Howe & Co. LLC owned approximately 0.63% of Inspire Medical Systems worth $34,795,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of the stock. Mutual of America Capital Management LLC raised its stake in Inspire Medical Systems by 1.2% in the 4th quarter. Mutual of America Capital Management LLC now owns 4,540 shares of the company's stock worth $842,000 after purchasing an additional 55 shares in the last quarter. MML Investors Services LLC grew its holdings in shares of Inspire Medical Systems by 0.9% during the 4th quarter. MML Investors Services LLC now owns 7,941 shares of the company's stock worth $1,472,000 after purchasing an additional 67 shares in the last quarter. Mariner LLC increased its position in shares of Inspire Medical Systems by 1.6% in the fourth quarter. Mariner LLC now owns 4,837 shares of the company's stock worth $897,000 after purchasing an additional 77 shares during the period. Wealth Enhancement Advisory Services LLC grew its stake in Inspire Medical Systems by 1.0% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 7,879 shares of the company's stock worth $1,461,000 after buying an additional 79 shares in the last quarter. Finally, Xponance Inc. raised its position in shares of Inspire Medical Systems by 2.2% in the 4th quarter. Xponance Inc. now owns 3,824 shares of the company's stock valued at $709,000 after buying an additional 82 shares in the last quarter. 94.91% of the stock is owned by institutional investors.

Inspire Medical Systems Stock Performance

INSP stock traded up $1.67 during trading on Tuesday, hitting $159.78. 400,952 shares of the company traded hands, compared to its average volume of 582,240. The company has a 50-day moving average of $162.45 and a 200-day moving average of $180.71. Inspire Medical Systems, Inc. has a 1 year low of $123.00 and a 1 year high of $257.40. The firm has a market capitalization of $4.76 billion, a PE ratio of 92.36, a P/E/G ratio of 2.86 and a beta of 1.39.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last released its quarterly earnings results on Monday, February 10th. The company reported $1.15 EPS for the quarter, beating analysts' consensus estimates of $0.74 by $0.41. Inspire Medical Systems had a return on equity of 8.19% and a net margin of 6.67%. Sell-side analysts expect that Inspire Medical Systems, Inc. will post 2.16 EPS for the current year.

Wall Street Analysts Forecast Growth

INSP has been the topic of several recent analyst reports. Royal Bank of Canada decreased their price target on Inspire Medical Systems from $260.00 to $215.00 and set an "outperform" rating on the stock in a research note on Tuesday, April 15th. Piper Sandler decreased their target price on shares of Inspire Medical Systems from $260.00 to $233.00 and set an "overweight" rating on the stock in a research note on Monday, February 10th. KeyCorp cut their price objective on Inspire Medical Systems from $234.00 to $216.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. Wells Fargo & Company lowered their target price on Inspire Medical Systems from $198.00 to $195.00 and set an "equal weight" rating for the company in a report on Tuesday, February 11th. Finally, Truist Financial reduced their price target on Inspire Medical Systems from $250.00 to $235.00 and set a "buy" rating on the stock in a report on Tuesday, February 11th. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to MarketBeat, Inspire Medical Systems currently has an average rating of "Moderate Buy" and an average target price of $218.90.

Insiders Place Their Bets

In other news, insider Randy Ban sold 25,584 shares of the firm's stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $183.50, for a total value of $4,694,664.00. Following the transaction, the insider now owns 7,259 shares of the company's stock, valued at $1,332,026.50. This trade represents a 77.90 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CTO John Rondoni sold 583 shares of the business's stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $170.49, for a total value of $99,395.67. Following the completion of the transaction, the chief technology officer now owns 10,424 shares in the company, valued at $1,777,187.76. The trade was a 5.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 4.10% of the company's stock.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.